Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ORIC · NASDAQ · Pharmaceutical Preparations
$7.36−0.34 (−4.42%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Oric Pharmaceuticals (ORIC) · oqro.io/stocks/ORIC · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
T. Rowe Price Associates, Inc. cut its ORIC stake below 5% (4.9%)Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
EcoR1 Capital, LLC cut its ORIC stake below 5% (2.9%)SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Viking Global disclosed a reduced position in ORIC for Q3 2026SourceInsider trade · Traded Oct 20, 2026 · Filed Oct 21, 2026
CFO sold ~$189K of ORIC shares in the open marketSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 2, 2026
Director sold ~$45K of ORIC shares in the open marketSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 2, 2026
Director sold ~$41K of ORIC shares in the open marketSourceInsider trade · Traded Sep 28, 2026 · Filed Sep 29, 2026
CFO sold ~$181K of ORIC shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 25, 2026
CFO sold ~$6.8K of ORIC shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 25, 2026
CFO sold ~$1.4K of ORIC shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP no longer reported ORIC for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in ORIC for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global disclosed a reduced position in ORIC for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Viking Global disclosed a reduced position in ORIC for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in ORIC for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Paradigm Biocapital Advisors LP disclosed a reduced position in ORIC for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed an increased position in ORIC for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP disclosed a new position in ORIC for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed an increased position in ORIC for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. no longer reported ORIC for Q3 2025SourceInsider trade · Traded Sep 22, 2025 · Filed Sep 24, 2025
CEO sold ~$1.35M of ORIC shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in ORIC for Q2 2025SourceInsider trade · Traded Jul 1, 2025 · Filed Jul 2, 2025
CFO sold ~$201K of ORIC shares in the open marketSourceInsider trade · Traded Jun 20, 2025 · Filed Jun 24, 2025
Director purchased ~$250K of ORIC shares in the open marketSourceInsider trade · Traded Jun 23, 2025 · Filed Jun 24, 2025
Director purchased ~$13K of ORIC shares in the open marketSourceInsider trade · Traded Jun 24, 2025 · Filed Jun 24, 2025
CFO sold ~$341K of ORIC shares in the open marketSourceInsider trade · Traded Jun 23, 2025 · Filed Jun 24, 2025
CFO sold ~$4.5K of ORIC shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Viking Global disclosed an increased position in ORIC for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in ORIC for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in ORIC for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Viking Global disclosed an increased position in ORIC for Q4 2024SourceInsider trade · Traded Dec 16, 2024 · Filed Dec 17, 2024
CEO sold ~$204K of ORIC shares in the open marketSourceInsider trade · Traded Dec 16, 2024 · Filed Dec 17, 2024
CFO sold ~$73K of ORIC shares in the open marketSourceInsider trade · Traded Dec 16, 2024 · Filed Dec 17, 2024
Officer sold ~$73K of ORIC shares in the open marketSourceInsider trade · Traded Jun 23, 2025 · Filed Jun 24, 2025
CFO sold ~$5.8K of ORIC shares in the open marketSourceInsider trade · Traded Jun 12, 2025 · Filed Jun 13, 2025
CFO sold ~$3K of ORIC shares in the open marketSourceInsider trade · Traded Jun 11, 2025 · Filed Jun 11, 2025
CFO sold ~$17K of ORIC shares in the open marketSourceInsider trade · Traded Jun 11, 2025 · Filed Jun 11, 2025
CFO sold ~$13K of ORIC shares in the open marketSourceInsider trade · Traded Jun 10, 2025 · Filed Jun 11, 2025
CFO sold ~$3.2K of ORIC shares in the open marketSourceInsider trade · Traded Jun 6, 2025 · Filed Jun 10, 2025
CFO sold ~$26K of ORIC shares in the open marketSourceInsider trade · Traded Jun 9, 2025 · Filed Jun 10, 2025
CFO sold ~$3K of ORIC shares in the open marketSource